Altium Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Altium Capital Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-77,848	Closed	-$3.09M	–	84
2024 Q1	$3.09M	Sell	77,848 -875	-1%	-$25.8K	1.22%	28
2023 Q4	$1.5M	Buy	+78,723	New	+$1.09M	1.02%	25

Altium Capital Management's ALPN Position: Q2 2024 in Review

Altium Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 77,848 shares — an estimated $3.09M sold.

Altium Capital Management first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $3.09M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Altium Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Altium Capital Management sold 77,848 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $3.09M.
Altium Capital Management first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
Altium Capital Management's Alpine Immune Sciences Inc position peaked at $3.09M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Altium Capital Management's 13F filing for Q2 2024, filed 15 Aug 2024.